U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07793552) titled 'Needlefree Lidocaine Application for Vulvar Biopsies' on Aug. 12. Brief Summary: The goal ... Read More
U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07793370) titled 'Evaluation of PTHrP, RANKL, and OPG Levels in Periodontal Health and Diseases' on Aug. 26. ... Read More
U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792980) titled 'AI-Assisted Microbiome Analysis for Evaluating the Efficacy of MPRO3 and Gut Environmental ... Read More
U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792889) titled 'AIM 3 Focused Adaptation of a Mobile Caregiver Intervention for Dementia Caregivers' on Aug... Read More
Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More
Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More
Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More
Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More